[Management of metastatic neuroendocrine tumors]

Ann Pathol. 2011 Nov;31(5 Suppl):S85-6. doi: 10.1016/j.annpat.2011.08.016. Epub 2011 Sep 21.
[Article in French]
No abstract available

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Antineoplastic Agents / therapeutic use
  • Cell Differentiation
  • Combined Modality Therapy
  • Disease Management
  • Enzyme Inhibitors / therapeutic use
  • Everolimus
  • Humans
  • Neuroendocrine Tumors / drug therapy
  • Neuroendocrine Tumors / pathology
  • Neuroendocrine Tumors / radiotherapy
  • Neuroendocrine Tumors / secondary*
  • Sirolimus / analogs & derivatives
  • Sirolimus / therapeutic use

Substances

  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • Enzyme Inhibitors
  • Everolimus
  • Sirolimus